FUCA1 and small cell lung carcinoma: The Galα1-3(Fucα1-2) Gal binder EEL showed an increase in NFIs in BPD, LD-SCLC and ED-SCLC compared with HV (all fold change ≥ 1.99, p ≤ 0.23), but a decrease in NFIs was observed in ED-SCLC compared with BPD and LD-SCLC (all fold change ≤ 0.34, p ≤ 0.047).